[ U.S. CDMRP – Peer-Reviewed Medical Research Program Technology/Therapeutic Development Award | Research Funding ]
Event details
| Date | 23.04.2020 |
| Category | Call for proposal |
Aim: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the Peer-Reviewed Medical Research Program (PRMRP) Awards. The PRMRP Technology/Therapeutic Development Award is a product-driven award mechanism intended to provide support for the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or improvement of quality of life. The product(s) to be developed may be a tangible item such as a pharmacologic agent (drugs or biologics) or device, or a knowledge-based product. Proof of concept demonstrating the potential utility of the proposed product, or a prototype/ preliminary version of the proposed product, should already be established.
Relevance to the healthcare needs of military Service members, Veterans, military beneficiaries, and/or the American public is a key feature of this award. Applications are required to include an explanation of how the proposed project has relevance to military health.
All applications for PRMRP funding must specifically address at least one of the Topic Areas as directed by Congress and have direct relevance to military health. The FY20 PRMRP Topic Areas are listed at the end of this announcement.
Funding: max. $4’000’000
Duration: 4 years
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. PI applicants must be independent investigators at or above the level of Assistant Professor (or equivalent).
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a preproposal narrative, and a list of collaborators and key personnel as suggested on the platform. Full applications (by invitation) will be made via a Grants.gov workspace. Full application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 23-Apr-2020, 5:00 p.m. EST
Full Application Deadline: 20-Aug-2020, 11:59 p.m. EST
Grants.gov Funding Opportunity Number: W81XWH-20-PRMRP-TTDA
Further information
FY20 Topic Areas
Relevance to the healthcare needs of military Service members, Veterans, military beneficiaries, and/or the American public is a key feature of this award. Applications are required to include an explanation of how the proposed project has relevance to military health.
All applications for PRMRP funding must specifically address at least one of the Topic Areas as directed by Congress and have direct relevance to military health. The FY20 PRMRP Topic Areas are listed at the end of this announcement.
Funding: max. $4’000’000
Duration: 4 years
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. PI applicants must be independent investigators at or above the level of Assistant Professor (or equivalent).
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a preproposal narrative, and a list of collaborators and key personnel as suggested on the platform. Full applications (by invitation) will be made via a Grants.gov workspace. Full application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 23-Apr-2020, 5:00 p.m. EST
Full Application Deadline: 20-Aug-2020, 11:59 p.m. EST
Grants.gov Funding Opportunity Number: W81XWH-20-PRMRP-TTDA
Further information
- To see the program announcement, navigate to the search page on Grants.gov and search for the Opportunity Number W81XWH-20-PRMRP-TTDA
- For questions about the eBRAP or Grants.gov platforms, contact the Research Office.
FY20 Topic Areas
- Arthritis
- Burn Pit Exposure
- Chronic Migraine and Post-Traumatic Headache
- Congenital Heart Disease
- Constrictive Bronchiolitis
- Diabetes
- Dystonia
- Eating Disorders
- Emerging Viral Diseases
- Endometriosis
- Epidermolysis Bullosa
- Familial Hypercholesterolemia
- Fibrous Dysplasia
- Focal Segmental Glomerulosclerosis
- Food Allergies
- Fragile X
- Frontotemporal Degeneration
- Guillain-Barré Syndrome
- Hemorrhage Control
- Hepatitis B
- Hydrocephalus
- Immunomonitoring of Intestinal Transplants
- Inflammatory Bowel Diseases
- Interstitial Cystitis
- Metals Toxicology
- Mitochondrial Disease
- Musculoskeletal Health
- Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
- Myotonic Dystrophy
- Nutrition Optimization
- Pancreatitis
- Pathogen-Inactivated Blood Products
- Plant-Based Vaccines
- Polycystic Kidney Disease
- Pressure Ulcers
- Pulmonary Fibrosis
- Resilience Training
- Respiratory Health
- Rheumatoid Arthritis
- Sleep Disorders and Restriction
- Spinal Muscular Atrophy
- Sustained Release Drug Delivery
- Vascular Malformations
- Women’s Heart Disease
Practical information
- General public
- Free